Q2 2026 · Form 13F Ledger数据来源:SEC EDGAR  
H

HOLDER.TOP

谁持有什么——美股机构持仓的季度账本。
EN · 简 · 繁
机构 / Ra Capital Management, L.P.
Form 13F · Q2 2026

Ra Capital Management, L.P.

CIK 1346824申报日 2026-08-1413F-HR 在 EDGAR 查看原始申报 ↗
$115.1亿
申报组合市值
85
持仓数量
12
Quarters on record
Top 50
持仓数量

Ra Capital Management, L.P.——持仓

共 85 个持仓中的前 50 名,按申报市值排名。股数变动与上一季度对比。
#证券股数股数环比市值占其组合
1ASND Ascendis Pharma A/S10.3M—$27.4亿23.8%
2PBLS Parabilis Medicines Inc28.9M—$7.9亿6.9%
3RYTM Rhythm Pharmaceuticals Inc6.7M+0.0%$7.4亿6.4%
4PCVX Vaxcyte Inc11.5M+0.0%$6.7亿5.8%
5SION Sionna Therapeutics Inc9.9M+0.0%$4.4亿3.8%
6TYRA Tyra Biosciences Inc12.2M+0.0%$3.9亿3.4%
7EWTX Edgewise Therapeutics Inc8.4M−19.5%$3.4亿3.0%
8NAMS Newamsterdam Pharma Company9.6M+0.0%$3.2亿2.8%
9COAG Hemab Therapeutics Hldgs Inc7.8M—$2.9亿2.5%
10SEPN Septerna Inc7.0M+0.0%$2.3亿2.0%
11BCAX Bicara Therapeutics Inc7.3M+0.0%$2.2亿1.9%
12MLYS Mineralys Therapeutics Inc7.7M+0.0%$2.1亿1.8%
13GHRS Gh Research Plc7.6M−0.5%$2.1亿1.8%
14IRON Disc Medicine Inc2.5M+0.0%$1.8亿1.6%
15SGP Spyglass Pharma Inc8.0M+0.0%$1.8亿1.6%
16ARTV Artiva Biotherapeutics Inc18.0M+82.2%$1.7亿1.5%
17JANX Janux Therapeutics Inc11.2M+0.0%$1.7亿1.5%
18TSHA Taysha Gene Therapies Inc23.6M+0.0%$1.6亿1.4%
19BCRX Biocryst Pharmaceuticals Inc15.8M+0.0%$1.6亿1.4%
20WVE Wave Life Sciences Ltd27.0M+0.0%$1.6亿1.4%
21NUVALENT INC Nuvalent Inc1.2M−50.8%$1.5亿1.3%
22ABVX Abivax Sa1.1M—$1.5亿1.3%
23ORKA Oruka Therapeutics Inc1.6M—$1.5亿1.3%
24CLYM Climb Bio Inc11.3M+0.0%$1.5亿1.3%
25SLDB Solid Biosciences Inc12.0M+28.9%$1.2亿1.0%
26ZLAB Zai Lab Ltd5.7M+0.6%$1.1亿0.9%
27SPRY Ars Pharmaceuticals Inc10.9M+0.0%$8700万0.8%
28XNCR Xencor Inc5.3M+7.7%$8492万0.7%
29JBIO Jade Biosciences Inc3.7M+0.0%$8157万0.7%
30NTLA Intellia Therapeutics Inc4.5M—$7660万0.7%
31LBRX Lb Pharmaceuticals Inc2.2M+0.0%$7168万0.6%
32DFTX Definium Therapeutics Inc1.5M—$7056万0.6%
33ACRS Aclaris Therapeutics Inc12.7M+87.0%$6730万0.6%
34FDMT 4D Molecular Therapeutics In5.0M+0.0%$6716万0.6%
35SANA Sana Biotechnology Inc18.8M—$6544万0.6%
36DMRA Damora Therapeutics Inc2.4M+0.0%$6242万0.5%
37MNPR Monopar Therapeutics Inc667,207+0.0%$6178万0.5%
38ABOS Acumen Pharmaceuticals Inc21.0M+0.0%$5605万0.5%
39GERN Geron Corp42.8M−32.9%$5480万0.5%
40RZLT Rezolute Inc9.4M+2.9%$4911万0.4%
41EVMN Evommune Inc3.5M+0.0%$4644万0.4%
42VOR Vor Biopharma Inc2.4M−55.6%$4422万0.4%
43IPSC Century Therapeutics Inc17.8M+0.0%$4350万0.4%
44AKTS Aktis Oncology Inc1.3M−12.6%$4236万0.4%
45BIOA Bioage Labs Inc1.7M+1.3%$4097万0.4%
46CCCC C4 Therapeutics Inc8.0M+0.0%$3736万0.3%
47MIRM Mirum Pharmaceuticals Inc318,554+0.0%$3729万0.3%
48CAPR Capricor Therapeutics Inc1.5M+0.0%$3631万0.3%
49PEPG Pepgen Inc20.1M+0.0%$3612万0.3%
50PRLD Prelude Therapeutics Inc6.5M—$3452万0.3%
来源:经 SEC EDGAR 的 Form 13F 申报。持仓截至 2026 年 6 月 30 日。期权(看涨/看跌)不计入股数。